L
Larissa Lezina
Researcher at University of Leicester
Publications - 12
Citations - 771
Larissa Lezina is an academic researcher from University of Leicester. The author has contributed to research in topics: Histone & Regulation of gene expression. The author has an hindex of 9, co-authored 12 publications receiving 573 citations. Previous affiliations of Larissa Lezina include Saint Petersburg State Institute of Technology.
Papers
More filters
Journal ArticleDOI
Lysine-Specific Demethylase 1 Regulates the Embryonic Transcriptome and CoREST Stability
Charles T. Foster,Oliver M. Dovey,Larissa Lezina,Jin Li Luo,Timothy W. Gant,Nick Barlev,Allan Bradley,Shaun M. Cowley +7 more
TL;DR: Lysine-specific demethylase 1 regulates the expression and appropriate timing of key developmental regulators, as part of the LSD1/CoREST/HDAC complex, during early embryonic development.
Journal ArticleDOI
Characterization of novel markers of senescence and their prognostic potential in cancer.
Mohammad Althubiti,Larissa Lezina,Samantha Carrera,Rebekah Jukes-Jones,Susan Giblett,Alexey V. Antonov,Nickolai A. Barlev,G S Saldanha,Catrin Pritchard,Kelvin Cain,Salvador Macip +10 more
TL;DR: The results could facilitate the study of senescence, define potential new effectors and modulators of this cellular mechanism and provide potential diagnostic and prognostic tools to be used clinically.
Journal ArticleDOI
Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor
Francesco Canfarotta,Larissa Lezina,Antonio Guerreiro,Joanna Czulak,Alexey Petukhov,Alexandra Daks,Katarzyna Smolinska-Kempisty,Alessandro Poma,Sergey A. Piletsky,Nickolai A. Barlev +9 more
TL;DR: This approach can provide a plausible alternative to conventional antibodies and sets up a new paradigm for the therapeutic application of this class of materials against clinically relevant targets, and nanoMIPs can promote the development of cell imaging tools against difficult targets such as membrane proteins.
Journal ArticleDOI
miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress.
Larissa Lezina,Larissa Lezina,N. Purmessur,Alexey V. Antonov,T. Ivanova,E. Karpova,K. Krishan,Mircea Ivan,Vasilisa Aksenova,D. Tentler,A V Garabadgiu,Gerry Melino,Gerry Melino,Nickolai A. Barlev,Nickolai A. Barlev +14 more
TL;DR: The bioinformatics analysis of survival times for patients with breast and prostate cancers has revealed that co-expression of mir-16 and miR-26a correlated with a better survival outcome, and provides a novel mechanism whereby p53 represses Chk1 and Wee1 expression, at least partially, via upregulation of miRs and thus sensitizes tumour cells to genotoxic therapies.
Journal ArticleDOI
Extracellular vesicles released by CD40/IL-4–stimulated CLL cells confer altered functional properties to CD4 + T cells
Dawn T. Smallwood,Benedetta Apollonio,Shaun Willimott,Larissa Lezina,Afaf Alharthi,Ashley R. Ambrose,Giulia De Rossi,Alan G. Ramsay,Simon D. Wagner +8 more
TL;DR: A novel role for CLL-EVs in modifying T- cell function that highlights unanticipated complexity of intercellular communication that may have implications for bidirectional CD4(+) T-cell:tumor interactions within the TME is revealed.